These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 1493462
1. Successful treatment of fungal infections in neutropenic patients with liposomal amphotericin (AmBisome)--a report on 40 cases from a single centre. Chopra R, Fielding A, Goldstone AH. Leuk Lymphoma; 1992; 7 Suppl():73-7. PubMed ID: 1493462 [Abstract] [Full Text] [Related]
2. Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients. Chopra R, Blair S, Strang J, Cervi P, Patterson KG, Goldstone AH. J Antimicrob Chemother; 1991 Oct; 28 Suppl B():93-104. PubMed ID: 1778896 [Abstract] [Full Text] [Related]
3. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. Mills W, Chopra R, Linch DC, Goldstone AH. Br J Haematol; 1994 Apr; 86(4):754-60. PubMed ID: 7918068 [Abstract] [Full Text] [Related]
4. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study. Kelsey SM, Goldman JM, McCann S, Newland AC, Scarffe JH, Oppenheim BA, Mufti GJ. Bone Marrow Transplant; 1999 Jan; 23(2):163-8. PubMed ID: 10197802 [Abstract] [Full Text] [Related]
5. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data. Ng TT, Denning DW. Arch Intern Med; 1995 May 22; 155(10):1093-8. PubMed ID: 7748054 [Abstract] [Full Text] [Related]
6. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Tollemar J, Ringdén O, Andersson S, Sundberg B, Ljungman P, Tydén G. Bone Marrow Transplant; 1993 Dec 22; 12(6):577-82. PubMed ID: 8136741 [Abstract] [Full Text] [Related]
7. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS. N Engl J Med; 1999 Mar 11; 340(10):764-71. PubMed ID: 10072411 [Abstract] [Full Text] [Related]
14. A retrospective clinical comparison between antifungal treatment with liposomal amphotericin B (AmBisome) and conventional amphotericin B in transplant recipients. Tollemar J, Andersson S, Ringdén O, Tydén G. Mycoses; 1992 Mar 11; 35(9-10):215-20. PubMed ID: 1291871 [Abstract] [Full Text] [Related]
15. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial]. Rieger CT, Dittmer M, Ostermann H. Dtsch Med Wochenschr; 2007 Oct 11; 132(40):2062-6. PubMed ID: 17899499 [Abstract] [Full Text] [Related]
16. Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation. Krüger W, Stockschläder M, Sobottka I, Betker R, De Wit M, Kröger N, Grimm J, Arland M, Fiedler W, Erttmann R, Zander AR. Leuk Lymphoma; 1997 Feb 11; 24(5-6):491-9. PubMed ID: 9086439 [Abstract] [Full Text] [Related]